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Self-reduction of an Fe3+-ADP-adriamycin complex under anaerobic conditions and reduction of 
ferricytochrome c by the complex under aerobic conditions were strongly inhibited by ceruloplasmin, but 
not by superoxide dismutase or albumin at the same protein concentration. Ceruloplasmin, a protein with 
ferroxidase activity, is able to catalyse oxidation of Fe’+ to the ferric state. The inhibitory activity of 
ceruloplasmin towards reactions stimulated by the complex suggests that Fe’+ is formed during the self- 
reduction process. As expected, the Fe’+--ADP-adriamycin complex stimulated lipid peroxidation in 
which the Fe’+ moiety was implicated. This stimulation was again effectively prevented by ceruloplasmin 
but not by superoxide dismutase. 
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1. INTRODUCTION 
Ceruloplasmin, the copper-containing protein of 
extracellular fluids, has been shown to have impor- 
tant antioxidant properties towards peroxidising 
lipids [l-3]. These activities can be mainly ascrib- 
ed to its known ferroxidase activity resulting in a 
catalysed oxidation of Fe’+ to the ferric state as 
well as an ability to inactivate copper ions [4]. 
The anthracycline antitumour antibiotic 
adriamycin has been shown, in vivo, to induce 
peroxidation of cardiac lipids [5]. Studies in vitro, 
however, have shown that adriamycin itself does 
not stimulate lipid peroxidation until it is first co- 
ordinated with Fe3+ [6]. Authors in [6,7] proposed 
a mechanism for adriamycin-induced lipid perox- 
idation involving an Fe3+-chelated adriamycin 
complex in which the Fe3+ moiety of the complex 
could undergo self-reduction or enzymic reduction 
[6,71. 
If ceruloplasmin can catalyse oxidation of the 
Fe’+ moiety in the chelated complex, then 
Adriamycin Ferroxidase activity 
Oxygen radical 
adriamycin-iron-stimulated lipid peroxidation 
should be strongly inhibited by its ferroxidase ac- 
tivity. This work was undertaken to examine this 
proposal. 
2. MATERIALS AND METHODS 
2.1 .I Reagents 
Superoxide dismutase (spec. act. 2900 units/mg), 
albumin (bovine, fatty acid-free), cytochrome c 
(horse heart, type VI) and ceruloplasmin (human, 
type III) were obtained from Sigma. Adriamycin 
(doxorubicin hydrochloride) was a gift from 
Kyowa Hakko Co. Ferrocytochrome c was 
prepared by dithionite reduction of ferricyto- 
chrome c and passed through a Sephadex G-25 
column (1.5 x 12 cm) which had been equilibrated 
with 10 mM Tris-HCI buffer at pH 7.5, using the 
same buffer to remove excess dithionite. During 
and after elution of ferrocytochrome c, the buffer 
and eluate were gassed with nitrogen. 
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2.2. Phospholipid 
Microsomal phospholipid was extracted from 
rat liver microsomes using chloroform-methanol 
[8] and was freed from contaminating lipids (free 
fatty acids, cholesterol and its ester) by a silicic 
acid column chromatography [9]. 
2.3. Incubation experiments 
Components of the reaction mixture, such as 
phospholipid (as liposomes) and the Fe3+-ADP 
complex, were prepared just before use as in [7]. 
Components of the co-ordination complex, 
Fe3+-ADP or Fe3+-ADP-adriamycin were ex- 
pressed in molar concentrations. The 
Fe3+-ADP-adriamycin complex prepared under 
our experimental conditions had a co-ordination 
ratio of about 2 for the adriamycin (ligand) to Fe3+ 
(co-ordination metal) [6]. A Thunberg-type cell 
with a sidearm was employed for anaerobic condi- 
tions. The contents (0.2 mM adriamycin and en- 
zyme - when added - in 0.1 M Tris-HCI buffer, 
pH 7.5) of the cell were rapidly frozen using solid 
COZ, followed by evacuation at 8 mm Hg at room 
temperature, until the contents were completely 
thawed. This was repeated 8 times in all. The reac- 
tion was initiated by mixing the Fe3+-ADP com- 
plex held in the sidearm with the cell contents. 
fer (pH 7.5) was mixed with the Fe3+ 
(0.1 mM)-ADP (1.67 mM) complex under both 
anaerobic and aerobic conditions it showed a 
characteristic absorption band at 602 nm [7]. 
Under anaerobic conditions the intensity of absor- 
bance then decreased at 602 nm with increasing 
time, suggesting the self-reduction of the 
Fe3+-ADP-adriamycin complex in which Fe3+ 
was converted to Fe’+ (fig. 1, curve 1). Superoxide 
dismutase (0.05 mg/ml, 1.6 x 10m6 M) did not 
alter the original decay curve of the 
Fe3+-ADP-adriamycin complex (fig. 1, curve 2). 
The self-reduction process was biphasic, showing 
an initial slow reaction followed by a faster phase. 
The first response may represent he initiation of 
intramolecular electron transfer resulting in reduc- 
tion of the iron moiety. Ceruloplasmin 
(0.05 mg/ml, 3.3 x 10e7 M) caused almost com- 
plete inhibition of the initial phase (fig. 1, curve 3). 
However, inhibition did not last long, probably 
because of loss of ferroxidase activity under 
anaerobic conditions [ 111. A further consideration 
for the reaction response is the stoichiometry bet- 
ween Fe2+ in the complex and copper ions in the 
enzyme. Ceruloplasmin (with 6-7 copper 
For all incubation experiments, the reaction was 
initiated by the addition of Fe3+-ADP complex 
and continued at 37°C for the times indicated. 
2.4. Assays 
Self-reduction of the Fe3+-ADP-adriamycin 
complex under anaerobic conditions was measured 
by the decrease in absorbance at 602 nm [6,7]. 
Oxygen consumption was measured in an ‘In- 
stech’ oxygenometer (Model 102) with a Clark- 
type electrode [7]. 
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Oxidation and reduction of cytochrome c were 
monitored by changes in absorbance at 550 nm [7]. 
Fatty acid composition was determined by a 
modification of the method in [lo] using a Shimad- 
zu gas chromatograph (Model GC-4CM). 
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3. RESULTS 
3.1. Inhibition of self-reduction of the 
F$+-ADP-adriamycin complex by 
ceruloplasmin 
Fig.1. Decrease of a characteristic absorption band (at 
602 nm) for the Fe’+ -ADP-gdriamycin complex under 
anaerobic conditions. The reaction mixtures and 
experimental conditions are described in section 2. 1, 
Fe3+-adriamycin complex; 2, Fe3+-ADP-adriamycin 
complex plus superoxide dismutase; 3, 
Fe3+-ADP-adriamycin complex plus ceruloplasmin. 
Arrow indicates the time at which air was bubbled into 
When 0.2 mM adriamycin in 0.1 Tris-HCl buf- the reaction mixture. 
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atoms/molecule) would, in this reaction, show a 
copper concentration corresponding to about l/ 13 
of the iron present. Little or no inhibition of the 
decrease in absorbance at 602 nm was observed 
with heat-denatured ceruloplasmin (not shown). In 
all experiments, intensity at A602nm returned to the 
original level following re-oxygenation (fig. 1). 
3.2. Inhibition by ceruloplasmin of cytochrome c 
reduction by the Fe3+-ADP-adriamycin 
complex 
Ferricytochrome c was reduced to fer- 
rocytochrome c by the Fe3+-ADP-adriamycin 
complex under both anaerobic and aerobic condi- 
tions, suggesting an electron transfer from the 
Fe’+--ADP-adriamycin complex (or a structurally 
related complex) produced by its self-reduction [7]. 
If oxidation of the Fe2+-ADP-adriamycin com- 
plex is catalysed by ceruloplasmin, the reduction of 
d c 
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Fig.2. Effect of various proteins on the autooxidation of 
ferrocytochrome c (A), and on cytochrome c reduction 
by the Fe3+-ADP-complex (B), both in air. (A) The 
reaction mixture contained 0.018 mM ferrocytochrome 
c (freshly prepared) and protein at 0.05 mg/ml (or none) 
in 0.1 M Tris-HCI buffer (pH 7.5). 1, ferrocytochrome 
c (basal), basal plus superoxide dismutase or basal plus 
albumin; 2, basal plus ceruloplasmin; 3, basal plus heat- 
denatured ceruloplasmin. (B) The reaction mixture 
contained Fe3+ (0.1 mM)-ADP (1.67 mM)-adriamycin 
(0.2 mM), 0.018 mM ferricytochrome c and protein at 
0.05 mg/ml (or none) in 0.1 M Tris-HCI buffer (pH 
7.5). 1, ferricytochrome c plus Fe3+-ADP-adriamycin 
complex (basal); 2, basal plus superoxide dismutase; 3, 
basal plus ceruloplasmin; 4, basal plus heat-denatured 
ceruloplasmin; 5, basal minus Fe3+-ADP (control); 6, 
Fig.3. Oxygen consumption in the systems containing 
liposomes, the Fe3+--ADP-adriamycin complex and 
protein (or none). (A) The reaction mixture contained 
liposomes (0.85 pmol/ml), Fe3+ (0.1 mM)-ADP 
(1.67 mM)-adriamycin (0.2 mM) complex and protein 
(0.05 mg/ml) or none in 0.1 M Tris-HCl buffer (pH 
7.5). 1, Fe3+-ADP-adriamycin and liposomes (basal) 
or basal plus albumin; 2, basal plus ceruloplasmin; 3, 
basal plus heat-denatured ceruloplasmin; 4, basal plus 
superoxide dismutase; 5, basal minus the 
Fe3+-ADP-adriamycin complex; 6, basal minus 
liposomes. (B) The reaction mixture was the same as 
basal (1) in A. Arrow indicates the time at which 
control plus ceruloplasmin. ceruloplasmin (0.05 mg/ml) was added. 
cytochrome c by the Fe3+-ADP-adriamycin com- 
plex should also be inhibited by ceruloplasmin. As 
shown in fig.2A, autooxidation of fer- 
rocytochrome c under aerobic conditions was pro- 
moted by native as well as heat-denatured 
ceruloplasmin. This may be attributed to non- 
specific activity associated with commercially ob- 
tained preparations of ceruloplasmin. As shown in 
fig.2B, intact ceruloplasmin caused a strong inhibi- 
tion under aerobic conditions of the 
Fe3+-ADP-adriamycin-induced cytochrome c 
reduction, while heat-denatured ceruloplasmin 
showed only a slight inhibitory effect. Little or no 
inhibition was observed following the addition of 
albumin or superoxide dismutase at the same pro- 
tein concentration (0.05 mg/ml) as that for 
ceruloplasmin. 
3.3. Inhibition by ceruloplasmin of 
Fe3+-ADP-adriamycin stimulated lipid 
peroxidation 
Peroxidation of phospholipid liposomes in 
0.1 M Tris-HCI buffer (pH 7.5) was monitored by 
an increase in oxygen consumption and changes in 
the fatty acid composition of the phospholipids. 
Oxygen consumption was markedly enhanced by 
0 
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Table 1 
Effect of ceruloplasmin on phospholipid fatty acid composition after peroxidation stimulated by an 
Fe3+-ADP-adriamycin complex 
Incubation system= Fatty acid compositionb 
(mol/ 100 mol palmitic acid) 
16:0 18:0 18:l 18:2 20:4 22:6 
Sl Suspension of phospholipid micelles 100 71 33 57 100 24 
S2 Basal (after perodixation) 100 72 33 51 67 12 
S3 S2 + ceruloplasmin 100 72 33 55 84 18 
S4 S2 + heat-denatured ceruloplasmin 100 70 34 54 75 14 
S5 S2 + superoxide dismutase 100 73 33 53 76 16 
S6 S2 + albumin 100 72 33 51 67 13 
a The reaction mixtures and incubation conditions were the same as those described inthe legend to fig.3. Samples were 
incubated for 15 min 
b Results were expressed as means of 3 experiments which were reproducible to f 5% 
the addition of the Fe 3+-ADP complex to the 
liposomal system containing 0.2 mM adriamycin. 
Oxygen consumption was substantially inhibited 
by the addition of ceruloplasmin (fig.3A) either 
before or during the reaction (fig.3B). It was also 
inhibited, but to a much smaller extent, by heat- 
denatured ceruloplasmin and native superoxide 
dismutase (fig.3A). Albumin, at the same protein 
concentration as ceruloplasmin, did not affect ox- 
ygen consumption. Under similar conditions, 
destruction of polyunsaturated fatty acids, 
especially arachidonic (20 : 4) and docosahexaenoic 
(22 : 6) acids, induced by the addition of 
Fe3+-ADP-adriamycin was effectively prevented 
by ceruloplasmin but not by heat-denatured 
ceruloplasmin or intact superoxide dismutase 
(table 1). 
4. DISCUSSION 
It has been reported previously [6,7] that an 
Fe3+-ADP-adriamycin complex stimulates the 
peroxidation of phospholipid liposomes without 
the need to add a reducing system (e.g., NADH- 
dependent cytochrome P-450 reductase). Further- 
more, it has been suggested that the co-ordination 
complex is aerobically converted to a perferryl ion- 
complex, via the Fe2+ -ADP-adriamycin radical, 
which stimulates the observed lipid peroxidation 
[7]. However, the Fe3+ -ADP-adriamycin com- 
plex which is formed in Tris-HCl buffer 
can be dissociated into Fe3+-ADP (or 
Fe3+-ADP-phosphate) and adriamycin when pre- 
sent in a phosphate buffer. This has been observed 
to decrease stimulation of lipid peroxidation [12]. 
In addition, a simple Fe3+-adriamycin complex 
has also been observed to stimulate lipid peroxida- 
tion [6,13]. 
Here, the strong inhibitory effect of 
ceruloplasmin towards the spontaneous decrease in 
absorbance at 602 nm (due to the self-reduction of 
the Fe3+-ADP-adriamycin complex) under 
anaerobic conditions and also to reduction of 
cytochrome c by the Fe3+-ADP-adriamycin com- 
plex under aerobic conditions has been 
demonstrated. This clearly indicates that the 
reduced iron moiety in the complex, which can be 
produced both by self-reduction and in the 
presence of an electron acceptor, is re-oxidised in 
a reaction catalysed by ceruloplasmin. Further- 
more, ceruloplasmin offered a substantial protec- 
tion against Fe3+ -ADP-adriamycin-stimulated 
lipid peroxidation as monitored by 02 uptake and 
estimation of changes in liposomal phospholipid 
fatty acids. This indicates that a species of Fe’+ 
(possibly the perferryl ion derived from Fe’+ co- 
ordinated with ADP and adriamycin) plays an im- 
portant role in stimulating lipid peroxidation. In 
addition, a simple iron salt and iron chelate, 
Fe’+-ADP, may also contribute. 
The concentrations of superoxide dismutase 
used in the present experiments were far greater 
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than those required for its catalytic activity. 
Therefore, its inhibitory activity towards lipid 
peroxidation may not necessarily be of a truly en- 
zymic nature since superoxide dismutase at 5 x 
IO-’ M had no effect on lipid peroxidation 
stimulated by the Fe3+ -ADP-adriamycin complex 
with [7] or without NADH-cytochrome P-450 
reductase (not shown). 
From the present results and those obtained 
previously [7] we can tentatively propose the 
following scheme: 
Fe3+-ADP-ADM 6 Fe2+-ADP-ADM+ * 
Fe2+ + ADP + ADM+ (1) 
Fe2+-ADP-ADM’ + 02 -+ 
02.. Fe3+-ADP-ADM+ (2) 
02.. Fe3+-ADP-ADM’ - 
stimulates lipid peroxidation (3) 
Fe’+-ADP-ADM+ + Cyt(Fe3+) -
Fe3+-ADP-ADM+ + Cyt(Fe’+) (4) 
Fe2+-ADP-ADM+ + E(Cu2’) -+ 
Fe3+-ADP-ADM+ + E(Cu+) (5) 
where 02. .Fe3+-ADP-ADM+, Cyt and E repre- 
sent the perferryl ion complex, cytochrome c and 
ceruloplasmin, respectively. Reaction 5 should be 
considerably faster than reactions 2 and 4. 
In conclusion, an iron-ADP-adriamycin com- 
plex can undergo a self-reduction to produce active 
oxygen species able to stimulate lipid peroxidation. 
The reactivity of this species is dependent on the 
Fe’+ moiety which can be oxidised catalytically by 
the ferroxidase activity of the protein 
ceruloplasmin. 
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